| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S J Bhathena, H K Oie, A F Gazdar, N R Voyles, S D Wilkins, L Recan. Insulin, glucagon, and somatostatin receptors on cultured cells and clones from rat islet cell tumor. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:6295859. |
parent cells bound 4.12 +/- 0.46% insulin, 2.11 +/- 0.29% glucagon, and 2.49 +/- 1.24% somatostatin per 2 x 10(6) cells. |
1983-03-11 |
2023-08-12 |
rat |
| S J Bhathena, H K Oie, A F Gazdar, N R Voyles, S D Wilkins, L Recan. Insulin, glucagon, and somatostatin receptors on cultured cells and clones from rat islet cell tumor. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:6295859. |
characteristic hormone binding patterns were observed in insulin secreting versus somatostatin secreting clones. |
1983-03-11 |
2023-08-12 |
rat |
| S J Bhathena, H K Oie, A F Gazdar, N R Voyles, S D Wilkins, L Recan. Insulin, glucagon, and somatostatin receptors on cultured cells and clones from rat islet cell tumor. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:6295859. |
insulin secreting versus somatostatin secreting clones. |
1983-03-11 |
2023-08-12 |
rat |
| S J Bhathena, H K Oie, A F Gazdar, N R Voyles, S D Wilkins, L Recan. Insulin, glucagon, and somatostatin receptors on cultured cells and clones from rat islet cell tumor. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:6295859. |
insulin secreting clones bound less insulin than somatostatin and other noninsulin-secreting clones (p less than 0.02). |
1983-03-11 |
2023-08-12 |
rat |
| A D Cherrington, M P Diamond, D R Green, P E William. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog. Diabetes. vol 31. issue 10. 1983-03-11. PMID:6759225. |
we previously showed that infusion of glucagon at four times the basal rate into conscious dogs given somatostatin and basal replacement amounts of insulin caused hyperglycemia (217 15 mg/dl) for at least 3 h and an initial increment in hepatic glucose production of 5.5 0.8 mg/kg . |
1983-03-11 |
2023-08-12 |
dog |
| R F Rowley, G S Eisenbart. Selective binding of fluoresceinated-avidin to A-cells of sectioned pancreas. Diabetes. vol 31. issue 2. 1983-03-11. PMID:6759227. |
fitc-avidin binding was inhibited by excess unlabeled avidin, and by biotin, but not by glucagon, somatostatin, or insulin. |
1983-03-11 |
2023-08-12 |
human |
| R F Rowley, G S Eisenbart. Selective binding of fluoresceinated-avidin to A-cells of sectioned pancreas. Diabetes. vol 31. issue 2. 1983-03-11. PMID:6759227. |
conversely, avidin reacted with no insulin, somatostatin, or cells containing hpp. |
1983-03-11 |
2023-08-12 |
human |
| A Rabinovitch, C Quigley, T Russell, Y Patel, D H Mint. Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet (beta-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes. vol 31. issue 2. 1983-03-11. PMID:6759233. |
the effects of insulin were not associated with any significant changes in glucagon or somatostatin levels in the culture media. |
1983-03-11 |
2023-08-12 |
rat |
| M J Dobersen, J E Scharf. Preferential lysis of pancreatic B-cells by islet cell surface antibodies. Diabetes. vol 31. issue 5 Pt 1. 1983-03-11. PMID:6759262. |
the uptake of ethidium bromide was used to identify lysed cells and immunofluorescent staining with antisera to insulin, glucagon, somatostatin, or pancreatic polypeptide was used to identify the different islet cell types (b-, a-, d-, and pp-cells, respectively). |
1983-03-11 |
2023-08-12 |
rat |
| E J Barrett, R A DeFronzo, S Bevilacqua, E Ferrannin. Insulin resistance in diabetic ketoacidosis. Diabetes. vol 31. issue 10. 1983-03-11. PMID:6818069. |
the effect of "low-dose" (6--10 u/h) insulin treatment on the rate of decline of plasma glucose concentration was determined in 15 diabetic subjects admitted in ketoacidosis (plasma glucose = 948 79 mg/dl) and in six normal volunteers rendered hyperglycemic by a combined infusion of somatostatin and glucose (plasma glucose = 653 28 mg/dl). |
1983-03-11 |
2023-08-12 |
human |
| G Ribes, G Valette, J F Valette, M M Loubatieres-Marian. Effects of chronic administration of sodium 2 chloropropionate in normal and diabetic dogs. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:7152136. |
the 2 cp chronic administration did not change the plasma somatostatin, glucagon, and insulin levels. |
1983-03-11 |
2023-08-12 |
Not clear |
| G Ribes, G Valette, J F Valette, M M Loubatieres-Marian. Effects of chronic administration of sodium 2 chloropropionate in normal and diabetic dogs. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:7152136. |
in the alloxan-diabetic dogs, treated with insulin alone, blood glucose, ketone body concentrations, and plasma somatostatin and glucagon levels were elevated. |
1983-03-11 |
2023-08-12 |
Not clear |
| K Kawai, R H Unge. Inhibition of glucagon secretion by exogenous glucagon in the isolated, perfused dog pancreas. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:7152137. |
to determine if the glucagon-suppressing action of glucagon was mediated by an increase in glucagon-stimulated insulin or somatostatin secretion, these hormones were measured in the various experiments. |
1983-03-11 |
2023-08-12 |
dog |
| K Kawai, R H Unge. Inhibition of glucagon secretion by exogenous glucagon in the isolated, perfused dog pancreas. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:7152137. |
insulin and somatostatin increased significantly when glucagon was perfused with the glucose arginine-containing solution but did not rise significantly when the glucopenic buffer was used, although suppression of endogenous glucagon was similar in each instance. |
1983-03-11 |
2023-08-12 |
dog |
| K Kawai, R H Unge. Inhibition of glucagon secretion by exogenous glucagon in the isolated, perfused dog pancreas. Diabetes. vol 31. issue 6 Pt 1. 1983-03-11. PMID:7152137. |
evidence that insulin and/or somatostatin mediate this action could not be obtained. |
1983-03-11 |
2023-08-12 |
dog |
| A Kanatsuka, H Makino, J Kasanuki, M Osegawa, A Kumaga. Somatostatin and insulin secretion from pancreatic islets: studies on the effect of high K+, 9-aminoacridine and valinomycin. Metabolism: clinical and experimental. vol 32. issue 1. 1983-02-25. PMID:6129560. |
somatostatin and insulin secretion from pancreatic islets: studies on the effect of high k+, 9-aminoacridine and valinomycin. |
1983-02-25 |
2023-08-12 |
rat |
| A Kanatsuka, H Makino, J Kasanuki, M Osegawa, A Kumaga. Somatostatin and insulin secretion from pancreatic islets: studies on the effect of high K+, 9-aminoacridine and valinomycin. Metabolism: clinical and experimental. vol 32. issue 1. 1983-02-25. PMID:6129560. |
elevation in the extracellular potassium concentration from 5.5 to 16.5 mm, or 0.2 mm 9-aminoacridine, which decreases potassium permeability in plasma membrane, stimulated the release of somatostatin as well as insulin from the isolated rat pancreatic islets. |
1983-02-25 |
2023-08-12 |
rat |
| J L Fries, W A Murphy, J Sueiras-Diaz, D H Co. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat. Peptides. vol 3. issue 5. 1983-02-25. PMID:6129618. |
somatostatin antagonist analog increases gh, insulin, and glucagon release in the rat. |
1983-02-25 |
2023-08-12 |
rat |
| J L Fries, W A Murphy, J Sueiras-Diaz, D H Co. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat. Peptides. vol 3. issue 5. 1983-02-25. PMID:6129618. |
injection of this new peptide into the rat completely blocked the inhibitory effects of exogenous somatostatin on gh, insulin, and glucagon release. |
1983-02-25 |
2023-08-12 |
rat |
| F Märki, U M Bucher, J C Richte. Multiple subcutaneous injections of somatostatin induce tachyphylaxis of the suppression of plasma insulin, but not glucagon, in the rat. Regulatory peptides. vol 4. issue 6. 1983-02-25. PMID:6129682. |
multiple subcutaneous injections of somatostatin induce tachyphylaxis of the suppression of plasma insulin, but not glucagon, in the rat. |
1983-02-25 |
2023-08-12 |
rat |